Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹3,342 Cr₹1,858 Cr₹3,665 Cr₹3,101 Cr₹2,572 Cr

What is the latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS ?

The latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS is ₹3,342 Cr based on Mar2025 Consolidated results.
Year Sundry Debtors
Mar2025₹3,342 Cr
Mar2024₹1,858 Cr
Mar2023₹3,665 Cr
Mar2022₹3,101 Cr
Mar2021₹2,572 Cr

How is Sundry Debtors of GLENMARK PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2025 ₹3,342 Cr
79.83
Mar2024 ₹1,858 Cr
-49.30
Mar2023 ₹3,665 Cr
18.19
Mar2022 ₹3,101 Cr
20.57
Mar2021 ₹2,572 Cr -

Compare Sundry Debtors of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,701.6 Cr -5.5% 7.6% 55.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,782.0 Cr -1.6% 5.7% 7.7% Stock Analytics
DIVIS LABORATORIES ₹163,125.0 Cr -4.2% -1.4% 9.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,252.0 Cr -2.8% 5.7% 39.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,025.0 Cr -3.2% 1.2% 14.2% Stock Analytics
CIPLA ₹102,443.0 Cr -3.6% -3.7% -10.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-5.5%

7.6%

55.4%

SENSEX

-0.2%

-7.2%

3.5%


You may also like the below Video Courses